BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Izumi D, Ishimoto T, Miyake K, Eto T, Arima K, Kiyozumi Y, Uchihara T, Kurashige J, Iwatsuki M, Baba Y, Sakamoto Y, Miyamoto Y, Yoshida N, Watanabe M, Goel A, Tan P, Baba H. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc. Stem Cells. 2017;35:2027-2036. [PMID: 28699179 DOI: 10.1002/stem.2668] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Y, Xia L, Wang H, Oyang L, Su M, Liu Q, Lin J, Tan S, Tian Y, Liao Q, Cao D. Cancer stem cells in progression of colorectal cancer. Oncotarget. 2017;9:33403-33415. [PMID: 30279970 DOI: 10.18632/oncotarget.23607] [Cited by in Crossref: 73] [Cited by in F6Publishing: 78] [Article Influence: 14.6] [Reference Citation Analysis]
2 Sun LC, Qian HX. Screening for implicated genes in colorectal cancer using whole‑genome gene expression profiling. Mol Med Rep 2018;17:8260-8. [PMID: 29658574 DOI: 10.3892/mmr.2018.8862] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
3 Khan AQ, Al-Tamimi M, Uddin S, Steinhoff M. F-box proteins in cancer stemness: An emerging prognostic and therapeutic target. Drug Discov Today 2021:S1359-6446(21)00314-7. [PMID: 34265459 DOI: 10.1016/j.drudis.2021.07.006] [Reference Citation Analysis]
4 Honma S, Hisamori S, Nishiuchi A, Itatani Y, Obama K, Shimono Y, Sakai Y. F-Box/WD Repeat Domain-Containing 7 Induces Chemotherapy Resistance in Colorectal Cancer Stem Cells. Cancers (Basel) 2019;11:E635. [PMID: 31067777 DOI: 10.3390/cancers11050635] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hidayat M, Mitsuishi Y, Takahashi F, Tajima K, Yae T, Miyahara K, Hayakawa D, Winardi W, Ihara H, Koinuma Y, Wirawan A, Nurwidya F, Kato M, Kobayashi I, Sasaki S, Takamochi K, Hayashi T, Suehara Y, Moriyama M, Moriyama H, Habu S, Takahashi K. Role of FBXW7 in the quiescence of gefitinib-resistant lung cancer stem cells in EGFR-mutant non-small cell lung cancer. Bosn J Basic Med Sci 2019;19:355-67. [PMID: 31202256 DOI: 10.17305/bjbms.2019.4227] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
6 Xiang X, Yuan D, Liu Y, Li J, Wen Q, Kong P, Gao L, Zhang C, Gao L, Peng X, Zhang X. PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression. Acta Biochim Biophys Sin (Shanghai) 2018;50:800-6. [PMID: 30020405 DOI: 10.1093/abbs/gmy076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
7 Li Y, Zu X, Hu X, Wang L, He W. Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer. Med Sci Monit 2019;25:8928-39. [PMID: 31761897 DOI: 10.12659/MSM.917345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Yan L, Lin M, Pan S, Assaraf YG, Wang ZW, Zhu X. Emerging roles of F-box proteins in cancer drug resistance. Drug Resist Updat 2020;49:100673. [PMID: 31877405 DOI: 10.1016/j.drup.2019.100673] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
9 Xu S, He Y, Lin L, Chen P, Chen M, Zhang S. The emerging role of ferroptosis in intestinal disease. Cell Death Dis 2021;12:289. [PMID: 33731703 DOI: 10.1038/s41419-021-03559-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
10 Ghatak S, Hascall VC, Markwald RR, Misra S. FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells. Int J Mol Sci 2021;22:E753. [PMID: 33451103 DOI: 10.3390/ijms22020753] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Izumi D, Toden S, Ureta E, Ishimoto T, Baba H, Goel A. TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer. Cell Death Dis 2019;10:267. [PMID: 30890693 DOI: 10.1038/s41419-019-1493-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
12 Zhao Y, Wang C, Goel A. Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancer. Carcinogenesis 2021;42:814-25. [PMID: 33822896 DOI: 10.1093/carcin/bgab027] [Reference Citation Analysis]
13 Sailo BL, Banik K, Girisa S, Bordoloi D, Fan L, Halim CE, Wang H, Kumar AP, Zheng D, Mao X, Sethi G, Kunnumakkara AB. FBXW7 in Cancer: What Has Been Unraveled Thus Far? Cancers (Basel) 2019;11:E246. [PMID: 30791487 DOI: 10.3390/cancers11020246] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 17.7] [Reference Citation Analysis]
14 Carreras-Dieguez N, Guerrero J, Rodrigo-Calvo MT, Ribera-Cortada I, Trias I, Jares P, López Del Campo R, Saco A, Munmany M, Marimon L, Ferrando M, Vega N, Del Pino M, Torné A, Ordi J, Rakislova N. Molecular Landscape of Vulvar Squamous Cell Carcinoma. Int J Mol Sci 2021;22:7069. [PMID: 34209172 DOI: 10.3390/ijms22137069] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Yang P, Wang Q, Liu A, Zhu J, Feng J. ALKBH5 Holds Prognostic Values and Inhibits the Metastasis of Colon Cancer. Pathol Oncol Res 2020;26:1615-23. [PMID: 31506804 DOI: 10.1007/s12253-019-00737-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
16 Kang XL, He LR, Chen YL, Wang SB. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis. World J Gastroenterol 2020; 26(43): 6853-6866 [PMID: 33268966 DOI: 10.3748/wjg.v26.i43.6853] [Reference Citation Analysis]
17 Lee HY, Hong IS. Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer. Cancers (Basel). 2020;12. [PMID: 32987767 DOI: 10.3390/cancers12102746] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
18 Yumimoto K, Nakayama KI. Recent insight into the role of FBXW7 as a tumor suppressor. Semin Cancer Biol 2020;67:1-15. [PMID: 32113998 DOI: 10.1016/j.semcancer.2020.02.017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
19 Gombodorj N, Yokobori T, Tanaka N, Suzuki S, Kuriyama K, Kumakura Y, Yoshida T, Sakai M, Sohda M, Baatar S, Miyazaki T, Nishiyama M, Shirabe K, Kuwano H. Correlation between high FBXW7 expression in pretreatment biopsy specimens and good response to chemoradiation therapy in patients with locally advanced esophageal cancer: A retrospective study: GOMBODORJ et al.. J Surg Oncol 2018;118:101-8. [DOI: 10.1002/jso.25127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
20 Bu L, Baba H, Yasuda T, Uchihara T, Ishimoto T. Functional diversity of cancer-associated fibroblasts in modulating drug resistance. Cancer Sci 2020;111:3468-77. [PMID: 33044028 DOI: 10.1111/cas.14578] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
21 Nolta JA. Research Leads to Approved Therapies in the New Era of Living Medicine. Stem Cells 2018;36:1-3. [PMID: 29210150 DOI: 10.1002/stem.2748] [Reference Citation Analysis]
22 Xu X, Zhang X, Wei C, Zheng D, Lu X, Yang Y, Luo A, Zhang K, Duan X, Wang Y. Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis. Eur J Pharm Sci 2020;152:105450. [PMID: 32621966 DOI: 10.1016/j.ejps.2020.105450] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
23 Gong J, Zhou Y, Liu D, Huo J. F-box proteins involved in cancer-associated drug resistance. Oncol Lett 2018;15:8891-900. [PMID: 29805625 DOI: 10.3892/ol.2018.8500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
24 Savage P. Chemotherapy Curability in Leukemia, Lymphoma, Germ Cell Tumors and Gestational Malignancies: A Reflection of the Unique Physiology of Their Cells of Origin. Front Genet 2020;11:426. [PMID: 32582272 DOI: 10.3389/fgene.2020.00426] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]